The US Food and Drug Administration has banned the use of Red No. 3, however, manufacturers have about two years to remove ...
Rosuvastatin has possible interactions with alcohol, some other drugs, and certain supplements. Examples include antacids ...
New Delhi: Pharmaceutical major Dr Reddy's has got approval from the Subject Expert Committee (SEC) functional under the ...
As advertisers pay more for an ever-scarcer supply of ratings points, pharma’s ironclad devotion to TV could finally be in ...
Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary ...
Hunter, Trooper, Scrappy and Buckaroo find zen by using Zenrelia <li /> Newly published study in a leading peer-reviewed, ...
Newly published study in a leading peer-reviewed, international journal, Veterinary Dermatology, compares clinical outcomes between Zenrelia and Apoquel® (oclacitinib tablet) ...
This retrospective analysis relied on Centers for Medicare and Medicaid Services payment data and information from anticancer drug package inserts, which could have introduced bias. Additionally ...
6d
2UrbanGirls on MSNAlliance for Pharmacy Compounding responds to Hims & Hers Super Bowl AdThe Hims & Hers planned Super Bowl ad buy – and the content of that ad – is noteworthy, but not because it violates any ...
About Veru Inc. Veru is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of cardiometabolic diseases, oncology, and ARDS. The Company’s drug ...
ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson's disease ONAPGO is a wearable subcutaneous infusion ...
ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson's diseaseONAPGO is a wearable subcutaneous infusion devi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results